DEVELOPMENT AND SUBDIVISION Sample Clauses

DEVELOPMENT AND SUBDIVISION. It is contemplated by Owner and Agent that the real property currently subject to this Agreement will be reconfigured and subdivided into the lots designated on the subdivision map included in Exhibit L hereto (the "Subdivision Map") and that the Subdivision Map will be THIS AGREEMENT FOR LEASE IS CONFIDENTIAL AND PROPRIETARY consented to and executed by Owner and other third parties and recorded in the real estate records of San Mateo County, California (such reconfiguration, subdivision and recordation being referred to in this Agreement as the "Recordation"). Agent agrees to effect the Recordation as promptly as practicable and in any event no later than June 15, 1997 and that the failure to do so shall constitute an Event of Unit Termination as described in Exhibit K hereto. It is also contemplated (i) that the parcel designated as "Parcel B" on the Subdivision Map may, at the request of Agent, be conveyed by quitclaim deed from Owner to Agent provided that, simultaneously therewith Agent shall, for no consideration, convey such parcel to Shorebreeze, (ii) that any land currently owned by Owner and designated as "Shoreline Drive" on the Subdivision Map will be conveyed to the City of Redwood City, California via dedication to the City on the Subdivision Map, and (iii) that subsequent easements and rights-of-way will be required, and at the request of Agent will be granted by Owner, for the Headquarters Unit, for the Unit Improvements to be located on each of Redwood Unit Premises Nos. 2, 3, and 4, and in connection with the Shores Business Center of which such real property is a part, provided that in each instance, no easement or right-of-way shall materially impair the intended use or value of any such Unit. In each instance, the request of Agent to Owner to execute such easement or right-of-way shall be deemed to be the representation of the Agent that the grant thereof will not materially impair the intended use or value of any such Unit. The net cash amount of any reimbursements received by Owner from the City of Redwood City pursuant to the Development Agreement dated as of November 7, 1996 between the Owner and the City of Redwood City shall be credited against amounts owed by Agent to Owner under this Agreement or the Lease or, in Owner's sole discretion, deducted from the Unit Acquisition Cost of the Redwood Unit Premises on a pro rata basis.
AutoNDA by SimpleDocs
DEVELOPMENT AND SUBDIVISION. 56 Exhibit A The Lease Exhibit B Form of AFL Unit Leasing Record Exhibit C Form of Acquisition Certificate Exhibit D Form of Interim Advance Certificate Exhibit E Form of Certificate of Substantial Completion Exhibit F Form of Certificate of Increased Cost Exhibit G FF&E Specifications Exhibit H Environmental Affidavit Exhibit I Issues to be Addressed in Environmental Report Exhibit J Conditions for Acceptance by Owner of Joint Protection Title Insurance Policy Exhibit K Waiver Letter for Unit Premises at Twin Dolphin Drive and Redwood Shares Parkway, Redwood AMENDMENT NO. 1 Dated as of March 7, 1997 to LEASE AGREEMENT Dated as of February 14, 1995 between Flatirons Funding, Limited Partnership, as Lessor and Electronic Arts Redwood, Inc., as Lessee

Related to DEVELOPMENT AND SUBDIVISION

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • Development 3.1.1 Licensee agrees to and warrants that:

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Development Budget Attached hereto as Exhibit "B" and incorporated herein by this reference is the Development Budget in an amount equal to $_____________. Owner acknowledges and represents that the attached Development Budget includes the total costs and expenses to acquire, develop, renovate and construct the Real Property and the Apartment Housing.

  • Development Reports Beginning six months after Effective Date and ending on the date of first commercial sale of a Licensed Product in the United States, LICENSEE shall report to Cornell progress covering LICENSEE's (and Affiliate's and Sublicensee's) activities and efforts in the development of rights granted to LICENSEE under this Agreement for the preceding six months. The report shall include, but not be limited to, activities and efforts to develop and test all Licensed Products and obtain governmental approvals necessary for marketing the same. Such semi-annual reports shall be due within sixty days (60) of the reporting period and shall use the form as provided herein as Appendix C.

  • Development Program A. Development Activities to be Undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Development Plan As defined in Section 3.2(a).

  • Development and Regulatory Milestones With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: MILESTONE PAYMENT

  • Information Systems Acquisition Development and Maintenance a. Client Data – Client Data will only be used by State Street for the purposes specified in this Agreement.

  • Development Funding (a) Viewray will pay 3D Line the then U.S. Dollar equivalent of €[***] within three (3) days of the Effective Date for the engineering services required to develop/ deliver the Deliverable described in Section 2.1(a)(i).

Time is Money Join Law Insider Premium to draft better contracts faster.